EYED PHARMA

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 11872836.37,
      "delta_eur": -12975077.13,
      "before_eur": 24847913.5,
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 11872836.37,
      "delta_eur": -12975077.13,
      "before_eur": 24847913.5,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 5650039,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    },
    {
      "kind": "capital_increase",
      "after_eur": 2567500.0,
      "delta_eur": 1967500.0,
      "before_eur": 600000.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 5135000.0,
      "delta_eur": 2567500.0,
      "before_eur": 2567500.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 9242750.0,
      "delta_eur": 4107750.0,
      "before_eur": 5135000.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "C",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 7936208.77,
      "delta_eur": -1306541.23,
      "before_eur": 9242750.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 11840941.5,
      "delta_eur": 3904732.73,
      "before_eur": 7936208.77,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "C",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 27911299.5,
      "delta_eur": 15970358.0,
      "before_eur": 11940941.5,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "D",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 43881657.5,
      "delta_eur": 15970358.0,
      "before_eur": 27911299.5,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "D",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 24847913.5,
      "delta_eur": -19033744.0,
      "before_eur": 43881657.5,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 11872836.37,
      "delta_eur": -12975077.13,
      "before_eur": 24847913.5,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 5650039,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Quentin PIRET",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Tilleur",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2026-04-28",
    "filing_date": "2026-04-24",
    "act_kind_objet": "Objet de l\u0027acte : CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2026-04-24",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": null,
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "statuts coordonn\u00E9s"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 1338084,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 183333,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 966530,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 3162092,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Pierre BELICHARD",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-04-23",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme, \u00E0 la majorit\u00E9 des voix \u00E9mises, Monsieur Pierre BELICHARD en qualit\u00E9 d\u0027administrateur ind\u00E9pendant, avec effet au 23 avril 2025."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Robert TAUB",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-12-15",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme, \u00E0 la majorit\u00E9 des voix \u00E9mises, Monsieur Robert TAUB en qualit\u00E9 d\u0027administrateur de classe C, avec effet au 15 d\u00E9cembre 2024."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Philippe COMBAL",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-07-03",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme, \u00E0 la majorit\u00E9 des voix \u00E9mises Monsieur Jean-Philippe COMBAL en qualit\u00E9 d\u0027administrateur ind\u00E9pendant, avec effet \u00E0 ce jour."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marc FOIDART",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-07-03",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 la majorit\u00E9 des voix \u00E9mises, de renouveler les mandats de Monsieur Marc FOIDART en qualit\u00E9 d\u0027administrateur de classe A ... et ce avec effet \u00E0 ce jour."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Marie RAKIC",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-07-03",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 la majorit\u00E9 des voix \u00E9mises, de renouveler les mandats de ... Monsieur Jean-Marie RAKIC en qualit\u00E9 d\u0027administrateur de classe A ... et ce avec effet \u00E0 ce jour."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Eric BRANDT",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-07-03",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 la majorit\u00E9 des voix \u00E9mises, de renouveler les mandats de ... la SA NOSHAQ en qualit\u00E9 d\u0027administrateur de classe B, et ce avec effet \u00E0 ce jour."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "CEO",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie MESTDAGT",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois MEURGEY",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Administrateur de classe C",
      "person": {
        "rrn": null,
        "name": "Sofie BAETEN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Pierre BELICHARD",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Administrateur de classe C",
      "person": {
        "rrn": null,
        "name": "Robert TAUB",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Carolyn MYERS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Jean-Philippe COMBAL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie MESTDAGT",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-03-01",
      "evidence_quote": "Nomination d\u0027un nouveau CEO avec d\u00E9l\u00E9gation \u00E0 la gestion journali\u00E8re",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "director_out",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois MEURGEY",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "SRL OUKELOS",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-04-22",
      "evidence_quote": "D\u00E9mission de la SRL OUKELOS (administrateur ind\u00E9pendant, repr\u00E9sent\u00E9 de mani\u00E8re permanente par Fran\u00E7ois MEURGEY)",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Sofie BAETEN",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "SA QBIC VENTURE PARTNERS II",
        "address": null,
        "country": null,
        "legal_form": "SA"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-12-15",
      "evidence_quote": "D\u00E9mission de la SA QBIC VENTURE PARTNERS II (Administrateur de classe C, repr\u00E9sent\u00E9 de mani\u00E8re permanente par Sofie BAETEN)",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Pierre BELICHARD",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": "coopted",
      "compensated": null,
      "effective_date": "2025-04-23",
      "evidence_quote": "Confirmation de la nomination de Monsieur Pierre BELICHARD en sa qualit\u00E9 d\u0027administrateur ind\u00E9pendant",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 4
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "director_in",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Robert TAUB",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": "coopted",
      "compensated": null,
      "effective_date": "2024-12-15",
      "evidence_quote": "Confirmation de la nomination de Monsieur Robert TAUB en sa qualit\u00E9 d\u0027administrateur de classe C",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 4
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "director_out",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Carolyn MYERS",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-06-24",
      "evidence_quote": "Remplacement de Madame Carolyn MYERS par Monsieur Jean-Philippe COMBAL au titre d\u0027administrateur ind\u00E9pendant",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_renew",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Marc FOIDART",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Renouvellement des mandats d\u0027administrateur de Monsieur Marc FOIDART (classe A)",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 4
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_renew",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Jean-Marie RAKIC",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Renouvellement des mandats d\u0027administrateur de Monsieur Jean-Marie RAKIC (classe A)",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 4
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_renew",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Eric BRANDT",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ SA",
        "address": null,
        "country": null,
        "legal_form": "SA"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Renouvellement des mandats d\u0027administrateur de ... NOSHAQ SA (classe B, repr\u00E9sent\u00E9 de mani\u00E8re permanente par Eric BRANDT)",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 4
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "delegated_daily_management",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie MESTDAGT",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale mandate Madame M\u00E9lanie MESTDAGT pour proc\u00E9der aux publications requises.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-11-18",
    "filing_date": "2025-11-06",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d_administration",
      "date": "2024-02-20",
      "unanimous": true
    },
    {
      "body": "assembl\u00E9e_generale_ordinaire",
      "date": "2025-07-03",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "M\u00E9lanie MESTDAGT",
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 19033744.0,
      "currency": "EUR",
      "after_eur": 24847913.5,
      "delta_eur": -19033744.0,
      "before_eur": 43881657.5,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-11-20",
      "evidence_quote": "L\u2019Assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 l\u2019unanimit\u00E9, de r\u00E9duire le capital \u00E0 concurrence de dix neuf millions trente-trois mille sept cent quarante-quatre euros (19.033.744,00 \u20AC), par incorporation, en vue d\u2019apurer \u00E0 concurrence du m\u00EAme montant, les pertes subies figurant \u00E0 la situation comptable arr\u00EAt\u00E9e au 31 d\u00E9cembre 2022... En cons\u00E9quence, le capital est port\u00E9 de quarante-trois millions huit cent quatre-vingt-un mille six cent cinquante-sept euros cinquante centimes (43.881.657,50 \u20AC) \u00E0 vingt-quatre millions huit cent quarante-sept mille neuf cent treize euros cinquante centimes (24.847.913,50 \u20AC).",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-11-20",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer, \u00E0 la fonction de commissaire, la soci\u00E9t\u00E9 BDO EXPERTS COMPTABLES \u0026 CONSEILLERS FISCAUX, en abr\u00E9g\u00E9 BDO Experts Comptables, dont le si\u00E8ge est situ\u00E9 \u00E0 1930 Zaventem, Da Vincilaan 9 bo\u00EEte E.6, avec un si\u00E8ge d\u2019exploitation \u00E0 4651 Herve (Battice), Rue Waucomont 51, repr\u00E9sent\u00E9e par Monsieur C\u00E9dric ANTONELLI, pour une dur\u00E9e de 3 ans, renouvelable.",
    "firm_kbo": null,
    "firm_name": "BDO EXPERTS COMPTABLES \u0026 CONSEILLERS FISCAUX",
    "ibr_number": null,
    "individual_name": "C\u00E9dric ANTONELLI"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale conf\u00E8re au notaire soussign\u00E9 tous pouvoirs n\u00E9cessaires aux fins de coordonner les statuts.",
      "holder_kbo": null,
      "holder_name": "notaire soussign\u00E9",
      "scope_categories": [
        "publication",
        "coordination"
      ],
      "with_substitution": false
    },
    {
      "quote": "L\u2019assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Monsieur Marc FOIDART pour l\u2019ex\u00E9cution des r\u00E9solutions \u00E0 prendre sur les objets qui pr\u00E9c\u00E8dent.",
      "holder_kbo": null,
      "holder_name": "Marc FOIDART",
      "scope_categories": [
        "execution"
      ],
      "with_substitution": false
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 24847913.5,
      "delta_eur": -19033744.0,
      "before_eur": 43881657.5,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 5650039,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Manon DEPREZ",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Tilleur",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-11-23",
    "filing_date": "2023-11-21",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-11-20",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Quentin PIRET",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire"
  },
  "co_filed_documents": [
    "expedition",
    "statuts coordonn\u00E9s"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 1338084,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 183333,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 966530,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 3162092,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "BDO Experts Comptables",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur de classe C",
      "person": {
        "rrn": null,
        "name": "FUND\u002B",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "repr\u00E9sentant permanent de l\u0027administrateur \u00AB FUND\u002B \u00BB",
      "person": {
        "rrn": null,
        "name": "Lawrence VAN HELLEPUTTE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent de FUND\u002B",
      "person": {
        "rrn": null,
        "name": "Bert DE LEEUW",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 24847913.5,
      "delta_eur": -19033744.0,
      "before_eur": 43881657.5,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "C\u00E9dric ANTONELLI",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BDO EXPERTS COMPTABLES \u0026 CONSEILLERS FISCAUX",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "En suite de quoi l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer, \u00E0 la fonction de commissaire, la soci\u00E9t\u00E9 BDO EXPERTS COMPTABLES \u0026 CONSEILLERS FISCAUX, en abr\u00E9g\u00E9 BDO Experts Comptables, dont le si\u00E8ge est situ\u00E9 \u00E0 1930 Zaventem, Da Vincilaan 9 bo\u00EEte E.6, avec un si\u00E8ge d\u2019exploitation \u00E0 4651 Herve (Battice), Rue"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Bert DE LEEUW",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0629896521",
        "name": "FUND\u002B",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "La Soci\u00E9t\u00E9 Anonyme \u00AB FUND\u002B \u00BB, ayant son si\u00E8ge \u00E0 3000 Louvain, Groot Begijnhof 60, bo\u00EEte 1, reprise au registre des personnes morales sous le num\u00E9ro 0629.896.521, pour laquelle Monsieur Bert DE LEEUW, domicili\u00E9 \u00E0 8930 Lauwe (Menen) Weggevoerdenlaan 4 est d\u00E9sign\u00E9 comme repr\u00E9sentant permanent."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "Administrateur de Classe C",
      "person": {
        "rrn": null,
        "name": "Sofie Baeten",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Administrateur de Classe C",
      "person": {
        "rrn": null,
        "name": "Jean Van Nuwenborg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "Eyed Pharma"
  }
}

{
  "events": [
    {
      "kind": "rep_rotation",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Sofie Baeten",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": {
        "kbo": "0668.403.244",
        "name": "Qbic Venture Partner II NV",
        "address": "Hekers 3, 9051 Zwijnaarde",
        "country": "BE",
        "legal_form": "NV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2022-07-14",
      "evidence_quote": "La repr\u00E9sentante permanente de l\u0027Administrateur de classe C Qbic Venture Partner II NV, Hekers 3, 9051 Zwijnaarde avec le num\u00E9ro d\u0027entreprise 0668.403.244, devient \u00E0 partir du 14 juillet 2022, Mme Sofie Baeten, en remplacement de M. Jean Van Nuwenborg.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": "Sofie Baeten",
      "rep_rotation_old_rep": "Jean Van Nuwenborg",
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "LIEGE",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-04-04",
    "filing_date": "2023-03-24",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [],
  "is_correction": false,
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "Eyed Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "M\u00E9lanie MESTDAGT",
    "org_rep_person_name": null,
    "person_role_at_subject": "repr\u00E9sentant permanent"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean Van Nuwenborg",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0668403244",
        "name": "Qbic Venture Partner II NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-07-14",
      "evidence_quote": "La repr\u00E9sentante permanente de l\u0027Administrateur de classe C Qbic Venture Partner II NV, Hekers 3, 9051 Zwijnaarde avec le num\u00E9ro d\u0027entreprise 0668.403.244, devient \u00E0 partir du 14 juillet 2022, Mme Sofie Baeten, en remplacement de M. Jean Van Nuwenborg."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sofie Baeten",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0668403244",
        "name": "Qbic Venture Partner II NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-07-14",
      "evidence_quote": "La repr\u00E9sentante permanente de l\u0027Administrateur de classe C Qbic Venture Partner II NV, Hekers 3, 9051 Zwijnaarde avec le num\u00E9ro d\u0027entreprise 0668.403.244, devient \u00E0 partir du 14 juillet 2022, Mme Sofie Baeten, en remplacement de M. Jean Van Nuwenborg."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 15970358,
      "currency": "EUR",
      "after_eur": 43881657.5,
      "delta_eur": 15970358.0,
      "before_eur": 27911299.5,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-01-20",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide ensuite d\u2019augmenter le capital social \u00E0 concurrence de quinze millions neuf cent septante mille trois cent cinquante-huit euros (15.970.358 \u20AC) pour porter celui-ci de vingt-sept millions neuf cent onze mille deux cent nonante-neuf euros cinquante centimes (27.911.299,50 \u20AC), \u00E0 quarante-trois millions huit cent quatre-vingt-un mille six cent cinquante-sept euros cinquante centimes (43.881.657,50 \u20AC)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-01-20",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "decharge_granted",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Elle lui donne d\u00E9charge pour l\u2019exercice de son mandat",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Lawrence VAN HELLEPUTTE",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": "0629.896.521",
        "name": "FUND\u002B",
        "address": "Groot Begijnhof 60, bo\u00EEte 1, 3000 Louvain",
        "country": "BE",
        "legal_form": "SA"
      },
      "statutory": null,
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "La Soci\u00E9t\u00E9 Anonyme \u00AB FUND\u002B \u00BB, ayant son si\u00E8ge \u00E0 3000 Louvain, Groot Begijnhof 60, bo\u00EEte 1,",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "4"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": null,
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie MESTDAGT",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "l\u2019assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Madame M\u00E9lanie MESTDAGT pour l\u2019ex\u00E9cution des r\u00E9solutions",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": null,
      "person": {
        "rrn": null,
        "name": "Carolyn MYERS",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "l\u2019assembl\u00E9e g\u00E9n\u00E9rale conf\u00E8re au notaire soussign\u00E9 tous pouvoir pour effectuer la publication de la nomination de Madame Carolyn MYERS",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "correction",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": "rectification",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Manon DEPREZ",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Tilleur",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-01-24",
    "filing_date": "2023-01-20",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2023-01-20",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Quentin PIRET",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire associ\u00E9"
  },
  "co_filed_documents": [
    "une exp\u00E9dition de l\u0027acte",
    "les statuts coordonn\u00E9s",
    "les rapports dans le cadre de l\u0027augmentation de capital et l\u0027\u00E9mission des droits de souscription"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 43881657.5,
      "delta_eur": 15970358.0,
      "before_eur": 27911299.5,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur de classe C",
      "person": {
        "rrn": null,
        "name": "Pienter-Jan",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur de classe C",
      "person": {
        "rrn": null,
        "name": "Fund\u002B",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lawrence VAN HELLEPUTTE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0629896521",
        "name": "Soci\u00E9t\u00E9 Anonyme \u00AB FUND\u002B \u00BB",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide en cons\u00E9quence de proc\u00E9der \u00E0 la nomination, en qualit\u00E9 d\u2019 administrateur de classe C : \u2022 La Soci\u00E9t\u00E9 Anonyme \u00AB FUND\u002B \u00BB, ayant son si\u00E8ge \u00E0 3000 Louvain, Groot Begijnhof 60, bo\u00EEte 1, reprise au registre des personnes morales sous le num\u00E9ro 0629.896.521, pour laquelle Monsieu"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "rue Louis Plescia, 9 \u00E0 4102 Seraing (Ougr\u00E9e)",
        "city": "Seraing",
        "region": "waals_gewest",
        "street": "rue Louis Plescia",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "9",
        "locality_suffix": "(Ougr\u00E9e)"
      },
      "old_address": {
        "raw": "Avenue Hippocrate, 5-4000 Li\u00E8ge",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "Avenue Hippocrate",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "5",
        "locality_suffix": null
      },
      "effective_date": "2022-03-24",
      "evidence_quote": "En sa s\u00E9ance du 24 mars 2022, le conseil d\u0027administration a d\u00E9cid\u00E9, \u00E0 l\u0027unanimit\u00E9, de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante: rue Louis Plescia, 9 \u00E0 4102 Seraing (Ougr\u00E9e).",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "act_body",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "M. Jean-Pierre Dupont",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Li\u00E8ge",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-05-23",
    "filing_date": "2022-03-24",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2022-03-24",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "Eyed Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "M\u00E9lanie Mestdagt",
    "org_rep_person_name": null,
    "person_role_at_subject": "mandataire"
  },
  "co_filed_documents": [
    "D\u00E9claration de transfert de si\u00E8ge social",
    "Proc\u00E8s-verbal du conseil d\u0027administration du 24 mars 2022",
    "Pouvoirs de repr\u00E9sentation pour les formalit\u00E9s"
  ]
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Seraing",
        "region": null,
        "street": "rue Louis Plescia",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "9"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "Avenue Hippocrate",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "5"
      },
      "effective_date": "2022-03-24",
      "evidence_quote": "En sa s\u00E9ance du 24 mars 2022, le conseil d\u0027administration a d\u00E9cid\u00E9, \u00E0 l\u0027unanimit\u00E9, de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante: rue Louis Plescia, 9 \u00E0 4102 Seraing (Ougr\u00E9e)."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer_cross_border_in",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "rue Louis Plescia, 9 \u00E0 4102 Seraing (Ougr\u00E9e)",
        "city": "Seraing",
        "region": "waals_gewest",
        "street": "rue Louis Plescia",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "9",
        "locality_suffix": "(Ougr\u00E9e)"
      },
      "old_address": null,
      "effective_date": null,
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": true,
      "old_address_source": "act_body",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": null,
      "statutaire_vs_werkelijke": null,
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2022-05-23",
    "filing_date": "2022-03-24",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "conseil_d_administration",
    "date": "2022-03-24",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "FRILUNAL OF L\u0027ENTEPRISE DE LIEGE",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "M\u00E9lanie MESTDAGT",
    "org_rep_person_name": null,
    "person_role_at_subject": "mandataire"
  },
  "co_filed_documents": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 27911299.5,
      "delta_eur": 15970358.0,
      "before_eur": 11940941.5,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Denis KNOOPS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur de classe D",
      "person": {
        "rrn": null,
        "name": "Soci\u00E9t\u00E9 Anonyme SPARAXIS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur de classe D",
      "person": {
        "rrn": null,
        "name": "Soci\u00E9t\u00E9 Anonyme CORPAR",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "REWISE AD REVISEUR D\u0027ENTREPRISES SRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-12-20",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0508.599.605",
    "name_full": "EYED PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}